Reutericyclin, a specialized metabolite of Limosilactobacillus reuteri, mitigates risperidone-induced weight gain in mice

Reutericyclin, a specialized metabolite of Limosilactobacillus reuteri, mitigates risperidone-induced weight gain in mice

The role of xenobiotic disruption of microbiota, corresponding dysbiosis, and potential links to host metabolic diseases are of critical importance. In this study, we used a widely prescribed antipsychotic drug, risperidone, known to influence weight gain in humans, to induce weight gain in C57BL/6J...

Full description

Saved in:
Bibliographic Details
Main Authors: Fatima A. Aboulalazm, Alexis B. Kazen, Orlando deLeon, Susanne Müller, Fatima L. Saravia, Valery Lozada-Fernandez, Matthew A. Hadiono, Robert F. Keyes, Brian C. Smith, Stephanie L. Kellogg, Justin L. Grobe, Tammy L. Kindel, John R. Kirby
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Gut Microbes
Subjects:
Risperidone
reutericyclin
anti-obesogenic
energy balance
Limosilactobacillus reuteri
random forest
Online Access:https://www.tandfonline.com/doi/10.1080/19490976.2025.2477819
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/19490976.2025.2477819

Similar Items